计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
Moligand™ 级 提供 ≥95% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存,充氩。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 2 篇同行评审文献引用。
Mithramycin A is an antibiotic DNA/RNA polymerase and DNA binding transcriptional inhibitor observed to facilitate TNF-α and Fas-ligand induced apoptosis. As a DNA binding transcriptional inhibitor, mithramycin A binds to GC rich sequences located in the minor groove of DNA and is noted to be reversible and Mg2+ dependent. Additionally reported to a block transcriptional activation of the SV40 promoter via competitive binding against Sp1 transcription factor to GC rich areas in the early promoter. Mithramycin A is noted to supress TNF-α induced expression of fractalkine (CX3CL1) mRNA in a dose-dependent manner and to act as an effective differentiation agent of HL60 promyelocytic leukemia cellsA polymerase inhibitor that binds to GC rich sequences located in the minor groove of DNA;DNA binding fluorescent dye. Until 2000 it was used to reduce high levels of plasma calcium; Used as an antineoplastic agent
Mithramycin A is an antibiotic DNA/RNA polymerase and DNA binding transcriptional inhibitor observed to facilitate TNF-α and Fas-ligand induced apoptosis. As a DNA binding transcriptional inhibitor, mithramycin A binds to GC rich sequences located in the minor groove of DNA and is noted to be reversible and Mg2+ dependent. Additionally reported to a block transcriptional activation of the SV40 promoter via competitive binding against Sp1 transcription factor to GC rich areas in the early promoter. Mithramycin A is noted to supress TNF-α induced expression of fractalkine (CX3CL1) mRNA in a dose-dependent manner and to act as an effective differentiation agent of HL60 promyelocytic leukemia cells
A polymerase inhibitor that binds to GC rich sequences located in the minor groove of DNA;DNA binding fluorescent dye. Until 2000 it was used to reduce high levels of plasma calcium; Used as an antineoplastic agent
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机氧化合物 |
| 类(Class) | 有机氧化合物 |
| 亚类(Subclass) | 碳水化合物和碳水化合物结合物 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 寡糖 |
| 其他上位类(Alternative Parents) | 蒽 萘酚及其衍生物 O-糖基化合物 四氢萘 芳基烷基酮 1-羟基-4-未取代苯类化合物 氧烷 β-羟基酮 偶氮类 乙烯基酸 α-羟基酮 叔醇 仲醇 氧环化合物 缩醛 二烷基醚 有机氧化物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 1-羟基-4-未取代苯环化合物 - 1-萘酚 - 乙醛酸 - 酰基吡咯烷酮 - 羟基苯甲酸酯 - α-羟基酮 - 蒽醌 - 芳香族杂多环化合物 - 芳基烷基酮 - 芳基溴化物 - 苯基化合物 - β-羟基酮 - 羰基 - 二烷基醚 - 乙醚 - 糖基化合物 - 烃衍生物 - 酮 - O-羧基化合物 - 萜类化合物 - 有机氧化物 - 有机杂环化合物 - 氧杂环 - 氧杂环丁烷 - 醛基 - 三烷基醇 - 四氢吡啶 - 乙烯基羧酸 |
| 描述(Description) | 该化合物属于有机化合物中的寡糖类。这类碳水化合物由3至10个单糖单元通过糖苷键相互连接而成。 |
| 外部描述符(External Descriptors) | anthracycline antibiotic - carbohydrate-containing antibiotic - aureolic acid |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H302: 吞食有害
H361: 怀疑破坏生育力或未出生的孩子
P264: 处理后要彻底洗手。
P270: 使用本产品时,请勿进食、饮水或吸烟。
P330: 漱口
P301+P312: 如误吞咽:如感觉不适,呼叫急救中心/医生。
P308+P313: 如接触到或有疑虑:求医/就诊。
P501: 将内容物/容器处理到。。。